相关实验视频

Updated: Jan 9, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

血管蛋白-1与代谢功能障碍相关的脂肪性肝病之间的关联:一个横截面研究

Nan Wang¹, Jie Zhang¹, Jingjing Zhou¹

¹Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.

Diabetology & metabolic syndrome

|December 10, 2025

概括

较高的血管蛋白-1 (ANGPT1) 水平与代谢功能障碍相关的脂肪性肝病 (MASLD) 有关. 这一发现表明ANGPT1可能成为MASLD的潜在诊断和治疗点.

科学领域:

肝病学肝病学是一种肝病学.
代谢障碍代谢障碍代谢障碍
血管新生研究研究

背景情况:

与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及血管生成.
ангиопоетин-1 (ANGPT1) 是血管生成的一个关键调节剂.
循环ANGPT1水平与MASLD之间的关联尚未得到充分证实.

研究的目的:

研究血清ANGPT1水平与MASLD之间的关系.
确定ANGPT1是否可以作为MASLD的生物标志物.

主要方法:

对接受年度健康检查的成年人进行横截面研究.
人类测量和生物化学参数的测量.
统计分析包括曼·惠特尼U测试,千二测试,斯皮尔曼分析和后勤回归.

主要成果:

与对照组相比,MASLD患者的血清ANGPT1水平显著更高.
血清ANGPT1水平与四分位数中MASLD患病率呈正相关性.
后勤回归证实了ANGPT1和MASLD之间的显著正相关性,即使经过对共变量进行调整.

结论:

血清ANGPT1和MASLD之间存在显著的积极关联.
ANGPT1显示出作为MASLD的诊断生物标志物的潜力.
ANGPT1可能是MASLD的未来治疗点.

关键词:

血管新生素-1 是一种血管新生素.横截面研究横截面研究马斯尔德马斯尔德是什么意思

更多相关视频

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...